ARVEE194.51

Arvee Laboratories (India) Limited

· Unclassified
₹ CrorePeersSPCENETGVPTECHMCLNITIRAJASPINWALLJMASINTERCOMMcap ₹214 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)137.5188.08184.44184.44
Receivable Days (DSO)73.5379.64121.05121.05
Payable Days (DPO)142.4163.30127.81106.28
Cash Conversion Cycle (days)68.63104.42177.68199.21
Working Capital Turnover1.972.241.782.33
Asset Turnover0.791.010.730.73
Cash Conversion (CFO/Net Income)6.38-0.02-0.05-0.05
CFO/EBITDA2.24-0.01-0.04-0.04
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.